Loading
Sentiment · FY2026 Q2
As of FY2026 Q1, the Tellvest earnings-call sentiment score for Globe Life (GL) is 8/10.
Revenue grew 5.4% with operating EPS of $3.43, up 12%, as Globe Life articulated an AI strategy for enterprise-wide margin expansion. United American Medicare Supplement sales continued explosive growth, and mortality trends sustained the earnings improvement trajectory. Management raised FY2026 guidance from $14.95-$15.65 to $15.40-$15.90, driven by accelerated buybacks and refined Q3 assumption update estimates.
Scored from Globe Life’s FY2026 Q1 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin |
|---|---|---|---|---|---|---|
| FY2024 Q4 | $1.47B | +3.6% | $3.01 | +4.5% | 21.3% | 17.4% |
| FY2025 Q1 | $1.48B | +4.5% | $3.01 | +12.7% | 21.4% | 17.2% |
| FY2025 Q2 | $1.48B | +2.8% | $3.05 | +7.8% | 21.2% | 17.1% |
| FY2025 Q3 | $1.51B | +4.0% | $4.71 | +36.9% | 31.5% | 25.6% |
| FY2025 Q4 | $1.52B | +3.9% | $3.29 | +9.3% | 23.4% | 17.5% |
| FY2026 Q1 | $1.56B | +5.3% | $3.45 | +14.6% | 23.6% | 17.3% |
| FY2026 Q2 | $1.60B | +8.0% | $3.65 | +19.7% | 17.8% | 18.0% |